General information on chemical experiments

Chemical reactions
All air-and moisture-sensitive reactions were carried out in glassware that was ovendried (>130 °C) and cooled under nitrogen. Reaction vessels were sealed with rubber septa or Teflon®-coated caps and maintained in an inert environment under a positive pressure of anhydrous N 2 . Stirring was accomplished via magnetic, Teflon®-coated stir bars or mechanical stirrers that were oven-dried and cooled under a nitrogen atmosphere. Vessels containing light-sensitive compounds were covered with aluminum foil. Solid reagents were measured on a Mettler Toledo AB104-S balance. Air-and moisture-sensitive liquids were transferred via syringe or cannula under an atmosphere of N 2 . Reaction temperatures refer to the external or bath temperature in which the reaction vessel was partially immersed. Room temperature (r.t.) indicates an external temperature of 20-25 °C. Elevated temperatures were achieved by the use of a silicon oil bath heated by a nichrome wire under constant voltage. Temperatures of 0 °C and -78 °C were maintained with ice/water mixtures and dry ice/acetone mixtures, respectively. Temperatures in between were maintained by the periodic addition of dry ice to a bath of acetone or acetonitrile (CH 3 CN). The term in vacuo refers to the use of a rotary evaporator with an attached vacuum membrane pump. Residual solvents were removed using vacuum held at < 1.0 Torr.
Reagents and Solvents
Unless otherwise noted, all commercial solvents and reagents were used without further purification. Reagents were purchased from Sigma-Aldrich unless otherwise indicated. Dichloromethane (CH 2 Cl 2 ) was passed through an alumina drying column (Solvtek Inc.) using nitrogen pressure. 
Experimental Procedures and Analyses
1. Catalytic cleavage of 4b by 2: characterization of side products 5 and 6 2 (0.5 mg, 0.00088 mmol) was dissolved in 1.5 mL of DI water in a vial with stirring at room temperature. 4b (15 mg, 0.0413 mmol) was added to the stirring solution, and the reaction was stirred at room temperature for 5 hours. The reaction mixture was separated with RP-HPLC to yield 4a (2.2 mg, 0.0079 mmol), 5 (2.8 mg, 0.0088 mmol), and 6 (1.7 mg, 0.0047 mmol). 
Synthesis of alloc-protected luciferin 7
To a 10 mL round bottom flask with stir bar was added a solution of luciferin (20 mg, 0.07 mmol) in H 2 O (3 mL). 340µL 0.5M NaOH solution was added to the flask at 0 °C, leading to the solubilization of the luciferin. Allyl chloroformate (30µL, 0.282 mmol) was added to the mixture and the reaction stirred for 45 min, during which time the solution turned from fluorescent yellow to opaque white. The reaction mixture was carefully acidified to pH = 3 and the product was washed with H 2 O and centrifuged twice to collect the solids. The product was dried on a high vacuum to give 7 (10.6 mg, 41%) as a white solid, which was chromatographically homogenous by RP-HPLC. Since the background hydrolysis of 7 will complicate the bioluminescence readout, allocprotected aminoluciferin 4b, incorporating a hydrolytically more robust carbamate linker, was next selected for study Figure S3 . Product distributions of the reaction between 2 and 4b after 24 hours with varied catalyst load. ([4b] 0 = 390 µM. A = 500 µM 4b stock solution in DI water; B = 100 µM 2 stock solution in DI water. 0 mol%: 3.5 mL A+0 mL B+1 mL DI water; 1 mol%: 3.5 mL A+0.175 mL B+0.825 mL DI water; 2.5 mol%: 3.5 mL A+0.4375 mL B+0.5625 mL DI water; 5 mol% = 2.5 mL A+0.875 mL B+0.125 mL DI water. Total volume of each reaction = 4.5 mL.) 
Low Bioluminescence Intensity of the Positive Control
Low level of bioluminescence intensity was observed with the positive control in Figure 2 . One major factor is the concentrations used for the control and the substrate: the positive control was conducted at a significantly (20-fold) lower concentration of 4a (25 µM) relative to 4b (500 µM with 5 mol% catalyst load). The relative signal intensity is further impacted by the timing of signal collection. We have previously reported that when luciferase-transfected PC3M cells are treated with luciferin only, a very strong initial bioluminescence signal was observed, but the signal faded away rapidly, and is close to baseline after ~3 to 4 minutes. 4 Since the first bioluminescence image taken in Figure 2 was 2 minutes after the cells were treated with 2 due to the exposure time of the CCD camera, the first 2 images only captured the end of the initial burst of bioluminescence signal of the positive control, and the low level of bioluminescence in the remaining time was the fading "tail" approaching baseline that was 
Treatment Solutions (TS) and PBS Washes Analyses
(a) (b) Figure S11 . Concentration of (a) 2 and (b) 4b in extracellular treatment solutions (TS) and PBS washes of 4T1 cells calculated from calibration curves in Figure S10 . 
ICP-MS Analysis of Cell Lysates
4T1 cells were treated with 2 at varied concentrations identical to previous bioluminescence experiments (50 µM, 25 µM, 12.5 µM, and 0 µM) for 15 minutes. The cells were then washed with PBS and lysed with concentrated HCl (aq) . ICP-MS experiments were performed on the cell lysates by Stanford University Environmental Measurements Facility (Thermo Xseries II), and the result showed that no trace ruthenium was detected in the cell lysates ( Figure  S12 ). This observation further supported the hypothesis that 2 cleaves 4b extraceullarly. In addition, it suggests that 2 might have low affinity for cell membrane because if 2 had bound to cell membrane tightly, ruthenium is likely to be released from the membrane into the aqueous phase when the cells were lysed with concentration HCl (aq) . 
S10
Catalytic Cleavage of 4b by 2 in LNCaP Cells
To explore whether the catalytic activated bioluminescence can be extended to a different cell type, luciferase-transfected LNCaP cells (a human prostate adenocarcinoma cell line) were treated with 2 and 4b. When the cells were treated with 4b immediately followed by 2, dosedependent photon emission was observed. When the cells were treated with pre-catalyst 2 for 15 minutes, followed by a PBS wash to remove extracellular catalyst, and then treated with alloc-protected aminoluciferin 4b, no bioluminescence was observed. When the treatment order was reversed, bioluminescence was observed and peaked at about 25 minutes after treatment with 2. When either 2 or 4b was absent, no bioluminescence was observed ( Figure  S14 ). This is analogous to what was observed in the luciferase-transfected 4T1 cells, indicating that this system is robust across different cell lines. 
